GFAP and Alzheimer disease: In the lateral temporal cortex, the astrocytic glial fibrillary acidic protein (GFAP) increases with AD severity and correlates with amyloid and tau pathology (Buchanan et al., 2020), suggesting that gliosis could be a robust indicator of disease progression.